| Literature DB >> 16996037 |
Oleg V Dolotov1, Ekaterina A Karpenko, Lyudmila S Inozemtseva, Tamara S Seredenina, Natalia G Levitskaya, Joanna Rozyczka, Elena V Dubynina, Ekaterina V Novosadova, Lyudmila A Andreeva, Lyudmila Yu Alfeeva, Andrey A Kamensky, Igor A Grivennikov, Nikolay F Myasoedov, Jürgen Engele.
Abstract
The heptapeptide Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is an analog of the adrenocorticotropin fragment (4-10) which after intranasal application has profound effects on learning and exerts marked neuroprotective activities. Here, we found that a single application of Semax (50 microg/kg body weight) results in a maximal 1.4-fold increase of BDNF protein levels accompanying with 1.6-fold increase of trkB tyrosine phosporylation levels, and a 3-fold and a 2-fold increase of exon III BDNF and trkB mRNA levels, respectively, in the rat hippocampus. Semax-treated animals showed a distinct increase in the number of conditioned avoidance reactions. We suggest that Semax affects cognitive brain functions by modulating the expression and the activation of the hippocampal BDNF/trkB system.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16996037 DOI： 10.1016/j.brainres.2006.07.108
Source DB: PubMed Journal: Brain Res ISSN： 0006-8993 Impact factor: 3.252